146 related articles for article (PubMed ID: 15625249)
1. Recombinant factor VIIa: how safe is the stuff?
Roberts HR
Can J Anaesth; 2005 Jan; 52(1):8-11. PubMed ID: 15625249
[No Abstract] [Full Text] [Related]
2. A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
Mittal S; Watson HG
Br J Haematol; 2006 May; 133(4):355-63. PubMed ID: 16643441
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of major blood loss.
Mannucci PM; Levi M
N Engl J Med; 2007 May; 356(22):2301-11. PubMed ID: 17538089
[No Abstract] [Full Text] [Related]
4. rFVIIa--its thrombogenicity.
Aledort LM
Thromb Haemost; 2000 Sep; 84(3):522-3. PubMed ID: 11019987
[No Abstract] [Full Text] [Related]
5. Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases.
Chuansumrit A; Treepongkaruna S; Phuapradit P
Thromb Haemost; 2001 Apr; 85(4):748-9. PubMed ID: 11341519
[No Abstract] [Full Text] [Related]
6. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders.
Hedner U; Glazer S; Falch J
Transfus Med Rev; 1993 Apr; 7(2):78-83. PubMed ID: 8481602
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
Poon MC; d'Oiron R
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S55-68. PubMed ID: 10850567
[TBL] [Abstract][Full Text] [Related]
8. The use of recombinant factor VIIa in the treatment of bleeding disorders.
Roberts HR; Monroe DM; White GC
Blood; 2004 Dec; 104(13):3858-64. PubMed ID: 15328151
[TBL] [Abstract][Full Text] [Related]
9. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII as a universal haemostatic agent.
Hedner U
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.
William BM
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):327-8. PubMed ID: 18469559
[No Abstract] [Full Text] [Related]
12. Recombinant factor VIIa is a pan-hemostatic agent?
Aledort LM
Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
[No Abstract] [Full Text] [Related]
13. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
14. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
[No Abstract] [Full Text] [Related]
15. Recombinant activated factor VII for acute intracerebral hemorrhage.
Sheth KN
N Engl J Med; 2005 May; 352(20):2133-4; author reply 2133-4. PubMed ID: 15906433
[No Abstract] [Full Text] [Related]
16. Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage.
McCarthy GC; Allen TK; Habib AS
J Clin Anesth; 2012 Sep; 24(6):508-9. PubMed ID: 22986324
[No Abstract] [Full Text] [Related]
17. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
18. Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients.
Technol Eval Cent Assess Program Exec Summ; 2006 Oct; 21(10):1-2. PubMed ID: 17061400
[No Abstract] [Full Text] [Related]
19. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
Pepas LP; Arif-Adib M; Kadir RA
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
[TBL] [Abstract][Full Text] [Related]
20. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
Ramsey G
Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
